ArticleJAAD case reports2025

Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin.

Megan E McNamara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.